Peruse an online marketplace like Craigslist, and you’ll find coded classified ads for “Study Help” and “Study Hall”, or calls looking for a “Study Buddy”. Despite the scholarly language, these aren’t people looking for pre-final cram session. They’re plugs for Adderall: the trade name for a combination of amphetamine salts long prescribed as a first-choice treatment for attention deficit hyperactivity disorder (ADHD). It’s a drug that is, of late, in perilously short supply.
The US National Institute for Mental Health estimates that ADHD affects 4.4% of adults between the ages of 18 and 44. The number of adults treated for ADHD has increased in recent decades, attributable to the wider destigmatization of diagnosing the disorder in adults as well as the Covid-19 pandemic and its knockback effects on adult mental health. The Centers for Disease Control and Prevention has found that adult prescriptions for ADHD medication increased by 7.9% between 2020 and 2021, compared with a 1.4% average annual increase between 2016 and 2020. In 2021, doctors authorized in excess of 30m prescriptions for Adderall, serving nearly 4 million patients.
